Migraine is a neurological disorder which is characterized by the recurrent episodes of headache [
6] moderate-to-severe, with unilateral predominance, photo- or phonophobia, nausea or vomiting, and exaggeration from physical activities. When there is any somatosensory symptom present before the migraine attack, this is called a migraine with aura (MwA) [
7]. There is also a complicated and simple migraine. A migraine attack followed by a stroke received the name of complicated migraine. A number of researches on the connection of migraine and cerebrovascular disease and migraine and stroke, did not reveal consistent results [
1,
3,
8‐
10]. However, the next two cohort studies [
11,
12] showed an association between MwA and HS, and one of them showed an association between MwtA and HS [
11]. In the cohort prospective study of Kurth and colleagues, they found that women with active MwtA had no increased risk for a hemorrhagic stroke [
12]. A big nationwide, population-based cohort study of a Danish group of investigators revealed an increased risk among the patients with migraine for any cerebrovascular pathology, including HS. And in contrast to the results of the previous study, it was stated that the women suffering from the MwtA have also higher risk for a HS [
13]. Another study performed in Denmark among the migraineurs, showed a higher risk for cerebrovascular events among the migraineurs being treated with the triptans [
14]. In one of the latter studies on the mechanisms and risk factors for association of a migraine and stroke by Hassan and colleagues they mentioned several shared mechanisms for strokes in migraineurs. The first one is based on the combination of decrease of progenitor endothelial cells quantity circulation together with vessel wall changes [
15]. The second one is a hypertension, hyperlipidemia and platelet dysfunction [
16]. The third one is based on the NSAIDs overuse during migraine attacks, which leads to antithrombotic effect [
17].
However, our patient does not have any comorbid states, she does not take NSAIDs during her migraine attacks and moreover, she has a MwtA. Unfortunately, the patient did not undergo a head CT or fundoscopy, as well as genetic analysis for CADASIL or any other genetic cerebrovascular disease. However, the performed MRI and spectroscopy were helpful in excluding the differential diagnosis of neoplasm or secondary lesion. One of the most well known risk factors for HS is hypertension [
18‐
20]. And although, our patient was not suffering from hypertension, migraine attacks are known to be followed by an increased blood pressure [
21], which by itself or in the combination with other risk factors, such as a triptan intake, could lead to a HS in this case. Since the patient does not have vascular malformation, and the intraparenchymal hemorrhage size greatly decreased on the control brain MRI, as well as the absence of neurological symptoms, no surgical treatment is needed. The patient is supposed to continue taking migraine prophylactic treatment to control the blood pressure and migraine attacks. She expects no further complications of this event, as well as recurrent HS.